Product Program year 2025 Source: CMS Open Payments

FreeStyle Libre 3

Device Diabetes Care

PDI 00357599819002

Open in the dashboard

General payments

$9,531,015

200,519 payments

Research payments

$4,943,789

419 payments

Through program year 2025, $9,531,015 in general payments and $4,943,789 in research payments were reported against FreeStyle Libre 3 (Diabetes Care).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

6 rows
Year Kind Amount Payments
2025 General $3,736,817 62,553
2025 Research $3,944,118 314
2024 General $3,227,758 74,236
2024 Research $314,046 55
2023 General $2,566,441 63,730
2023 Research $685,625 50

Breakdown

Who paid General payments · program years 2023–2025
  1. Abbott Laboratories $9,531,015 200,519 payments
Top recipients General payments · program year 2025
  1. Bhakti Paul Internal Medicine · Raleigh, NC $88,879 2% · 93 payments
  2. Rosemarie Lajara Endocrinology, Diabetes & Metabolism · Plano, TX $86,995 2% · 121 payments
  3. Helen Baron Endocrinology, Diabetes & Metabolism · Rancho Mirage, CA $49,445 1% · 71 payments
  4. John Gilbert Endocrinology, Diabetes & Metabolism · Fullerton, CA $48,771 1% · 64 payments
  5. Barbara Hirsch Endocrinology, Diabetes & Metabolism · Manhasset, NY $46,418 1% · 66 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Endocrinology, Diabetes & Metabolism Internal Medicine $1,608,943 43% · 2,105 practitioners
  2. Family Medicine $559,740 15% · 7,741 practitioners
  3. Internal Medicine $456,808 12% · 4,991 practitioners
  4. Nurse Practitioner, Family Nurse Practitioner $318,069 9% · 4,424 practitioners
  5. Nurse Practitioner $201,164 5% · 1,175 practitioners

The top 5 of 175 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Texas $518,163 14% · 2,614 recipients
  2. California $378,152 10% · 1,872 recipients
  3. Florida $235,550 6% · 2,170 recipients
  4. New York $219,415 6% · 1,401 recipients
  5. North Carolina $179,949 5% · 994 recipients

The top 5 of 55 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

200,519 general · 419 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record